GV 2021 Gp, L.P. is 10% Owner at Prime Medicine, Inc. (PRME). They have made 1 open-market trade across 1 company since 2022, most recently 2023-06-21.
CIK 0001861216
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $23.0M since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRME | SELL · 10b5-1 | 2023-06-20 | 2023-06-22 | $15.03 | $1.7M | +1.6% | +0.1% | -19.7% |
| PRME | SELL · 10b5-1 | 2023-06-13 | 2023-06-15 | $14.95 | $1.3M | -0.9% | -1.1% | -16.8% |
| PRME | SELL · 10b5-1 | 2023-06-07 | 2023-06-09 | $16.75 | $586K | +4.3% | +3.9% | -14.1% |
| PRME | SELL · 10b5-1 | 2023-06-05 | 2023-06-07 | $16.88 | $1.8M | -8.5% | -12.8% | -27.8% |
| PRME | SELL · 10b5-1 | 2023-05-18 | 2023-05-22 | $13.63 | $2.5M | +12.7% | +5.4% | -14.8% |
| PRME | SELL · 10b5-1 | 2023-05-08 | 2023-05-10 | $14.09 | $11.9M | +4.4% | +6.0% | -7.0% |
| GTLB | BUY | 2022-05-10 | 2022-05-12 | $34.66 | $23.0M | -13.4% | +5.7% | +69.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.